Humanigen, Inc (HGEN) SEC Filing 8-K Material Event for the period ending Friday, June 28, 2019

Humanigen, Inc

CIK: 790816 Ticker: HGEN

View differences made from one to another to evaluate Humanigen, Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Humanigen, Inc.


Assess how Humanigen, Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Humanigen, Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: HGEN
CIK: 1293310
Form Type: 8-K Corporate News
Accession Number: 0001214659-19-004520
Submitted to the SEC: Fri Jul 05 2019 4:15:15 PM EST
Accepted by the SEC: Fri Jul 05 2019
Period: Friday, June 28, 2019
Industry: Pharmaceutical Preparations
  1. New Agreement
  2. New Financial Obligation

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: